Franklin Street Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $538K | Hold |
60,000
| – | – | 0.03% | 112 |
|
2025
Q1 | $450K | Hold |
60,000
| – | – | 0.03% | 114 |
|
2024
Q4 | $451K | Hold |
60,000
| – | – | 0.03% | 115 |
|
2024
Q3 | $456K | Hold |
60,000
| – | – | 0.03% | 111 |
|
2024
Q2 | $371K | Hold |
60,000
| – | – | 0.03% | 123 |
|
2024
Q1 | $305K | Hold |
60,000
| – | – | 0.02% | 136 |
|
2023
Q4 | $359K | Hold |
60,000
| – | – | 0.03% | 116 |
|
2023
Q3 | $425K | Buy |
60,000
+10,000
| +20% | +$70.8K | 0.04% | 107 |
|
2023
Q2 | $352K | Hold |
50,000
| – | – | 0.03% | 111 |
|
2023
Q1 | $417K | Hold |
50,000
| – | – | 0.04% | 97 |
|
2022
Q4 | $574K | Hold |
50,000
| – | – | 0.05% | 93 |
|
2022
Q3 | $630K | Hold |
50,000
| – | – | 0.06% | 95 |
|
2022
Q2 | $529K | Hold |
50,000
| – | – | 0.05% | 99 |
|
2022
Q1 | $813K | Hold |
50,000
| – | – | 0.07% | 93 |
|
2021
Q4 | $693K | Hold |
50,000
| – | – | 0.05% | 97 |
|
2021
Q3 | $719K | Hold |
50,000
| – | – | 0.06% | 95 |
|
2021
Q2 | $791K | Buy |
+50,000
| New | +$791K | 0.07% | 88 |
|
2021
Q1 | – | Sell |
-80,000
| Closed | -$596K | – | 150 |
|
2020
Q4 | $596K | Buy |
80,000
+5,000
| +7% | +$37.3K | 0.06% | 98 |
|
2020
Q3 | $258K | Hold |
75,000
| – | – | 0.03% | 124 |
|
2020
Q2 | $357K | Hold |
75,000
| – | – | 0.04% | 110 |
|
2020
Q1 | $150K | Buy |
75,000
+25,000
| +50% | +$50K | 0.02% | 128 |
|
2019
Q4 | $173K | Sell |
50,000
-14,000
| -22% | -$48.4K | 0.02% | 147 |
|
2019
Q3 | $183K | Buy |
64,000
+50,000
| +357% | +$143K | 0.02% | 150 |
|
2019
Q2 | $53K | Sell |
14,000
-50,000
| -78% | -$189K | 0.01% | 155 |
|
2019
Q1 | $521K | Buy |
64,000
+20,000
| +45% | +$163K | 0.07% | 105 |
|
2018
Q4 | $355K | Buy |
44,000
+1,000
| +2% | +$8.07K | 0.06% | 108 |
|
2018
Q3 | $328K | Hold |
43,000
| – | – | 0.04% | 124 |
|
2018
Q2 | $246K | Sell |
43,000
-6,000
| -12% | -$34.3K | 0.04% | 136 |
|
2018
Q1 | $234K | Hold |
49,000
| – | – | 0.04% | 140 |
|
2017
Q4 | $241K | Hold |
49,000
| – | – | 0.04% | 145 |
|
2017
Q3 | $257K | Hold |
49,000
| – | – | 0.04% | 126 |
|
2017
Q2 | $272K | Hold |
49,000
| – | – | 0.05% | 121 |
|
2017
Q1 | $412K | Hold |
49,000
| – | – | 0.07% | 116 |
|
2016
Q4 | $310K | Hold |
49,000
| – | – | 0.05% | 145 |
|
2016
Q3 | $216K | Sell |
49,000
-20,000
| -29% | -$88.2K | 0.04% | 167 |
|
2016
Q2 | $196K | Hold |
69,000
| – | – | 0.04% | 182 |
|
2016
Q1 | $195K | Hold |
69,000
| – | – | 0.04% | 204 |
|
2015
Q4 | $712K | Hold |
69,000
| – | – | 0.14% | 127 |
|
2015
Q3 | $787K | Hold |
69,000
| – | – | 0.16% | 122 |
|
2015
Q2 | $1.03M | Hold |
69,000
| – | – | 0.18% | 116 |
|
2015
Q1 | $623K | Sell |
69,000
-30,000
| -30% | -$271K | 0.11% | 130 |
|
2014
Q4 | $1.2M | Buy |
99,000
+6,000
| +6% | +$73K | 0.23% | 99 |
|
2014
Q3 | $910K | Hold |
93,000
| – | – | 0.17% | 117 |
|
2014
Q2 | $1.19M | Hold |
93,000
| – | – | 0.23% | 107 |
|
2014
Q1 | $984K | Sell |
93,000
-46,000
| -33% | -$487K | 0.2% | 114 |
|
2013
Q4 | $1.06M | Hold |
139,000
| – | – | 0.21% | 109 |
|
2013
Q3 | $1.01M | Hold |
139,000
| – | – | 0.23% | 110 |
|
2013
Q2 | $216K | Buy |
+139,000
| New | +$216K | 0.05% | 224 |
|